New Jersey Better Educational Savings Trust’s Sarepta Therapeutics SRPT Stock Holding History

New Jersey Better Educational Savings Trust’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,000	Closed	-$304K	–	170
2019 Q2	$304K	Hold	2,000	–	–	0.4%	88
2019 Q1	$238K	Sell	2,000 -1,200	-38%	-$154K	0.32%	126
2018 Q4	$349K	Buy	3,200 +200	+7%	+$25K	0.45%	67
2018 Q3	$485K	Buy	3,000 +1,000	+50%	+$137K	0.5%	64
2018 Q2	$264K	Buy	+2,000	New	+$189K	0.29%	133

Other funds holding SRPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

New Jersey Better Educational Savings Trust's SRPT Position: Q3 2019 in Review

New Jersey Better Educational Savings Trust sold out of Sarepta Therapeutics (SRPT) in Q3 2019, closing a stake of 2,000 shares — an estimated $304K sold.

New Jersey Better Educational Savings Trust first reported a position in SRPT in Q2 2018 and held it in 5 quarters. The position peaked at $485K in Q3 2018. 340 funds tracked by Wall St. Rank hold SRPT as of Q3 2019.

New Jersey Better Educational Savings Trust reported no remaining Sarepta Therapeutics position as of Q3 2019 after selling out during the quarter.
New Jersey Better Educational Savings Trust sold 2,000 Sarepta Therapeutics shares in Q3 2019, an estimated $304K.
New Jersey Better Educational Savings Trust first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 5 quarters.
New Jersey Better Educational Savings Trust's Sarepta Therapeutics position peaked at $485K in Q3 2018.
340 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2019.

Based on New Jersey Better Educational Savings Trust's 13F filing for Q3 2019, filed 18 Oct 2019.